Abstract TP423: Predictors of Elevated P Wave Terminal Force and NT-proBNP Differ in the ARCADIA Trial

David L. Tirschwell,W. T. Longstreth,Richard A. Kronmal,Mitchell S.V. Elkind,Seemant Chaturvedi,Joseph P. Broderick,Caitlyn Meinzer,Claudia S. Moy,Hooman Kamel

Abstract TP423: Predictors of Elevated P Wave Terminal Force and NT-proBNP Differ in the ARCADIA Trial

2020

David L. Tirschwell
W. T. Longstreth
Richard A. Kronmal
Mitchell S.V. Elkind
Seemant Chaturvedi
Joseph P. Broderick
Caitlyn Meinzer
Claudia S. Moy
Hooman Kamel

Background: Elevated P-wave terminal force velocity in ECG lead V1 (PTFV1) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are both associated with an increased risk of ischemic stroke and...

Keywords:

Cardiology
Internal medicine
Natriuretic peptide
Physical therapy
ecg lead
Clinical trial
Biomarker (medicine)
force velocity
Diabetes mellitus
increased risk
ischemic stroke
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations